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Abstract Carnitine is an amino acid derivative that plays a
key role in energy metabolism. Endogenous carnitine is found
in its free form or esterified with acyl groups of several chain
lengths. Quantification of carnitine and acylcarnitines is of
particular interest for screening for research and metabolic
disorders. We developed a method with online solid-phase
extraction coupled to high-performance liquid chromatogra-
phy and tandem mass spectrometry to quantify carnitine and
three acylcarnitines with different polarity (acetylcarnitine,
octanoylcarnitine, and palmitoylcarnitine). Plasma samples
were deproteinized with methanol, loaded on a cation ex-
change trapping column and separated on a reversed-phase
C8 column using heptafluorobutyric acid as an ion-pairing
reagent. Considering the endogenous nature of the analytes,
we quantified with the standard addition method and with
external deuterated standards. Solid-phase extraction and sep-
aration were achieved within 8 min. Recoveries of carnitine
and acylcarnitines were between 98 and 105 %. Both quanti-
ficationmethods were equally accurate (all values within 84 to
116 % of target concentrations) and precise (day-to-day
variation of less than 18 %) for all carnitine species and
concentrations analyzed. The method was used successfully
for determination of carnitine and acylcarnitines in different
human samples. In conclusion, we present a method for
simultaneous quantification of carnitine and acylcarnitines
with a rapid sample work-up. This approach requires small
sample volumes and a short analysis time, and it can be
applied for the determination of other acylcarnitines than the
acylcarnitines tested. The method is useful for applications in
research and clinical routine.
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Introduction
Carnitine is an endogenous compound that plays a crucial role
in energy metabolism. Carnitine is essential for the transport
of long-chain fatty acids into the mitochondrial matrix for
subsequent β-oxidation [1] and for the regulation of the
cellular coenzyme A (CoA) and acyl-CoA pools [2, 3]. These
functions of carnitine involve the acylation of its β-hydroxyl
group, leading to the formation of various acylcarnitines with
different chain lengths [4].
Analytical profiling of carnitine and its acyl derivatives
is used for instance to screen newborns and children for
metabolic disorders, to monitor patients at risk for or with
established hypocarnitinemia [5], and in research projects
about energymetabolism [3, 6, 7]. Primary carnitine deficiency
is a rare inherited disease which is caused by mutations in the
gene coding for OCTN2, the renal carnitine transporter [8, 9].
Secondary carnitine deficiency is observed more frequently for
instance in patients with organic acidurias [10, 11] and in
patients on hemodialysis [7, 12].
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Chromatographic methods for the quantification of car-
nitine and acylcarnitines in plasma use either HPLC or
capillary electrophoresis for separation and mostly MS/MS
for detection and quantification [13]. Sample preparation
can consist of several steps such as solid-phase extraction
[14–17] and esterification of carnitine and acylcarnitines at
their carboxyl groups with different alcohols to enhance
sensitivity [13, 15, 18]. Sample processing is time consum-
ing and imprecisions can potentially arise from incomplete
derivatization and/or hydrolysis of acylcarnitines during the
derivatization process [19].
Considering the endogenous nature of carnitine and
acylcarnitines, their quantification is mainly achieved with
surrogate matrices, such as dialyzed plasma or an albumin
solution [17] or with surrogate analytes, such as deuterated
compounds [13, 15, 17]. Both approaches use substitute pa-
rameters for the original matrix or analytes so that compara-
tive studies are required to ensure the validity of the method
[20]. In addition, deuterated compounds are expensive and
may not be available for all acylcarnitines.
For the analysis of clinical and research samples, time,
accuracy, and precision are important factors. Our principal
goal was to improve our existing method for plasma carnitine
and acylcarnitine analysis [17] by minimizing the time used
for sample preparation and by optimizing the quantification
procedure. A first specific aim was to establish a simple
sample work-up including a precipitation step followed by
an online extraction procedure and LC-MS/MS for separation
and quantification. A second specific aim was to eliminate the
impact of matrix effects on quantification, which can be a
problem for carnitine and acylcarnitines in biological matrices
[17, 21]. For that, we compared two methods, namely quanti-
fication using deuterated external standards and quantification
by the standard addition method (SAM). The newly developed
methods were fully validated and compared mutually as well
as with the conventional radioenzymatic method [22, 23].
Furthermore, the practicability of the methods was demon-
strated by the analysis of clinical samples.
Materials and methods
Reagents
L-carnitine, L-acetylcarnitine, and L-palmitoylcarnitinewere pur-
chased from Sigma (St. Louis, MO, USA). L-octanoylcarnitine
was obtained from Dr. H. J. ten Brink (VU Medical Center,
Amsterdam, The Netherlands). L-carnitine-d3, L-acetylcarnitine-
d3, L -octanoylcarnitine-d3, and L -palmitoylcarnitine-d3
were supplied by Cambridge Isotope Laboratories (Andover,
MA, USA).
All other chemicals and solvents were from Merck
(Darmstadt, Germany) or Sigma and were of analytical grade.
LC/MS-MS equipment
The HPLC system consisted of a HTS PAL autosampler (CTC
Analytics AG, Zwingen, Switzerland), a column-oven (CTO-
20A), a quaternary pump (LC-20AD) and a system controller
(CBM-20A) from Shimadzu (Reinach, Switzerland). The
HPLC system was coupled to an API4000 triple quadrupole
mass spectrometer from AB/MDS Sciex (Concord, Canada)
with an electrospray ionization source.
Samples were loaded on an Oasis MCX trapping column
(30μm, 2.1×20mm;Waters Corporation,Milford,MA, USA)
and separated on a Luna C8 5 μm column (150×2 mm)
equipped with a C8 (4×2.0 mm) precolumn (Phenomenex,
Torrance, CA, USA).
Sample preparation and carnitine determination
by LC/MS-MS
Blood samples were collected in tubes containing lithium
heparin. Plasma was obtained after centrifugation at 1,811×g
for 10 min and stored at −20 °C until analysis.
HPLC conditions
The chromatographic separation was done with a binary flow at
50 °C. Phase Awas an aqueous solution containing 5 mmol/L
heptafluorobutyric acid and 5 mmol/L ammonium acetate
and phase B was methanol with the same additives. During
1.5 min, the analytes were loaded on the trapping column
using 0.1 % formic acid in water (V /V) as mobile phase
(flow, 0.5–1.0 mL/min), whereas the analytical column was
conditioned with 10 % phase B (flow, 0.35 mL/min). After
valve switching, the analytes were transferred to the ana-
lytical column starting at 10 % phase B with a linear
increase of the gradient to 95 % phase B within 4 min.
After a plateau of 2 min at 95 % phase B, the analytical
column was re-equilibrated for 2 min with 10 % B. This
resulted in a total run time of 8 min. The chromatographic
conditions are shown in Electronic supplementary material
Fig. S1.
MS conditions
Carnitine and the acylcarnitines of interest were analyzed in the
positivemultiple reactionmonitoringmode.A first transitionwas
used for quantification, a second one for qualification. Following
transitions (m/z) were used: carnitine, 162→103 and 162→60;
carnitine-d3, 165→103 and 165→63; acetylcarnitine, 204→85
and 204→145; acetylcarnitine-d3, 207→85 and 207→145;
octanoylcarnitine, 288→85 and 288→229; octanoylcarnitine-
d3, 291→85 and 291→229; palmitoylcarnitine, 400→85
and 400→341; and palmitoylcarnitine-d3, 403→85 and
403→341, respectively.
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The ion spray voltage was 5,500 eV; the probe temperature
was 450 °C, and the dwell time was 50 ms for each analyte.
Quantification with the SAM
Plasma samples to be analyzed were divided in five aliquots of
10 μL. To each of the 10-μL aliquots, 0 to 40 μL of standard
solution in methanol was added in 10 μL steps. The volume of
all samples was brought to 50 μL with methanol. Standards
were prepared in methanol and contained (final concentra-
tions): carnitine, 10–40 μmol/L; acetylcarnitine, 5–20 μmol/L;
octanoylcarnitine, 0.25–1.0 μmol/L; and palmitoylcarnitine,
0.25–1.0 μmol/L. Afterwards, the plasma samples were
deproteinized with the addition of 200 μL methanol. The sam-
ples were extracted for 10 min at full speed on a Multi-tube
Vortexer (VX-2500, VWR International) and centrifuged at
3,220×g for 30 min.
For the determination of total carnitine, acylcarnitines were
hydrolyzed under alkaline conditions; 25 μL plasma was
mixed with 25 μL KOH 0.5 M (pH 13) and incubated at
40 °C for 30 min. The mixture was then neutralized with
50 μL at 1 % formic acid in water (V /V ) and centrifuged for
10 min at 1,811×g .
After quantification, the LC/MS-MS peak areas were fitted
to the added concentrations and the endogenous concentration
was calculated as the intercept of this curve on the x -axis.
Quantification with external deuterated standards (deuterated
standard method)
For this type of quantification, we constructed an external
calibration curve using the peak areas from deuterated stan-
dards in pooled plasma. Pooled plasma was spiked with deu-
terated compounds in the following concentration ranges (final
concentrations): carnitine-d3, 1–100 μmol/L; acetylcarnitine-
d3, 0.25–50 μmol/L; octanoylcarnitine-d3, 0.025–10 μmol/L;
and palmitoylcarnitine, 0.05-10μmol/L. These plasma samples
(10 μL) were then mixed with 200 μL methanol. After 10 min
shaking, the samples were centrifuged at 3,220×g for 30 min
and analyzed as described above.
Unspiked plasma samples were prepared identically and
the analyte concentration in these samples was calculated
using the calibration curve obtained with the deuterated stan-
dards. The sample and standard work-up for total carnitine
was identical as described for the SAM.
Quantification with the radioenzymatic method
The radioenzymatic method was used for hydrolyzed samples
as a comparison with the two LC/MS-MS methods. The
radioenzymatic method used by us [23] is based on the method
described by Brass and Hoppel [22].
Validation of the method
We determined accuracy and precision of both the SAM and
the deuterated standard method (DSM). Given the endoge-
nous nature of carnitine and its derivatives and the lack of
blank plasma, we used spiked plasma samples for these
determinations.
For the validation of the SAM, pooled plasma was spiked
with three concentrations of carnitine, acetylcarnitine,
octanoylcarnitine, and palmitoylcarnitine (low-, medium-,
and high-quality controls (QC)). These samples contained
the unknown endogenous concentration of the pooled plasma
plus 12.5, 25, or 37.5 μmol/L carnitine; 3, 6, or 9 μmol/L
acetylcarnitine; 0.03, 0.06, or 0.09 μmol/L octanoylcarnitine;
and 0.125, 0.25, or 0.375 μmol/L palmitoylcarnitine,
respectively.
For the validation of the DSM, pooled plasma was
spiked with three concentrations of deuterated carnitine,
acetylcarnitine, octanoylcarnitine, and palmitoylcarnitine.
The added concentrations were 1.25, 12.5, or 125 μmol/L
for carnitine-d3; 0.4, 4, or 40 μmol/L for acetylcarnitine-d3;
0.08, 0.8, or 8 μmol/L for octanoylcarnitine-d3; and 0.08, 0.8,
or 8 μmol/L for palmitoylcarnitine.
For total carnitine, the samples were hydrolyzed and the
concentration determined using the SAM. For comparison, the
same samples were also determined using the radioenzymatic
assay [22, 23].
Recovery was assessed with three concentrations of the
four analytes spiked before or after the protein precipitation
step. For the assessment of short-term stability, samples were
spiked, stored at room temperature for 8 h, analyzed, and
compared with freshly spiked samples. For stability under
storage conditions, samples were spiked and kept frozen
at −20 °C for 1 week. The samples were then analyzed
and compared with freshly spiked plasma samples. For
freeze/thaw stability, freshly prepared samples were frozen
at −20 °C for at least 12 h and then thawed at room temper-
ature for 30 min. After three freeze–thaw cycles, the samples
were analyzed and compared with freshly prepared samples.
To determine the stability of the analytes in solution, freshly
made stock solutions were analyzed and compared with stock
solutions that had been stored at −20 °C for 4 months.
The lower limit of quantification was defined as the lowest
concentration measured with precision and accuracy not
exceeding 20 % with a signal to noise ratio of >10.
Source of biological samples
To test the practical application of the method, two types of
plasma samples were obtained and analyzed. Samples were
obtained from two infants with medium-chain acyl-CoA de-
hydrogenase deficiency and from a healthy 58-year-old
man exercising until exhaustion. Exhaustive exercise was
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performed on a cycling ergometer, starting at a workload of
220 W with increases of 20 W every 2 min. Exhaustion was
achieved after having finished the 380 W workload phase.
Samples were obtained before exercise, in the middle of every
workload phase, and during the recovery phase up to 15 min
after termination of exercise.
Results and discussion
Probe preparation and analyte separation
A first aim of the current project was to develop a rapid and
reliable method with a one-step sample preparation that could
potentially be automated. Suchmethods usually have an initial
protein precipitation step which is followed by direct applica-
tion of the supernatant on the HPLC system and on-column
clean-up of the sample. Online solid-phase extraction coupled
to chromatographic separation in one run conciliates the ad-
vantages of solid-phase extraction with time efficiency. In
several publications, online solid-phase extraction followed
by LC-MS has been described for the analysis of carnitine and
certain acylcarnitines. Ho et al. [21] reported a procedure for
the analysis of free and total carnitine, whereas Hirche et al.
[24] described a method for the analysis of carnitine,
acetylcarnitine, and propionylcarnitine and for the carnitine
precursors butyrobetaine and trimethyllysine. Goshal et al.
[25] published a method for the analysis of carnitine and
acylcarnitines from C2 to C18 and at the same time demon-
strated their clinical applicability. The run time of the HPLC
step was 17 min for this method, however, which we consid-
ered too long. As shown previously [16], the addition of
heptafluorobutyric acid as an ion-pairing agent to the HPLC
solvents results in sharper peaks and allows achieving a good
separation.We followed this strategy and achieved a sufficient
separation of carnitine, butyrobetaine, and acylcarnitines from
C2 to C18 within 6 min, resulting in a total run time of 8 min
(Fig. 1; Electronic supplementary material (ESM) Fig. S2).
This run time is longer than the 4.5 min described by Ho et al.
[21], but Ho et al. only analyzed free and total carnitine and
not acylcarnitines. In comparison, run times were between 16
and 75 min in other published methods analyzing carnitine
and acylcarnitines [14, 15, 17, 25].
Offline solid-phase extraction after the initial protein pre-
cipitation step is a frequently used alternative [14–17, 26] for
the online procedure that we used in the current study. As
carnitine and acylcarnitines are cations under acidic condi-
tions, matrices with cation exchange properties are preferred
to optimize retention [15, 17]. This is the reason why we also
used a cation exchanger for online sample clean-up in the
current study.While offline solid-phase extraction can enhance
the sensitivity of the chromatographic assays, the process is
usually time-consuming and difficult to automate.
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Fig. 1 Representative LC-MS/MS multiple reaction monitoring chromato-
grams of carnitine, acetylcarnitine, octanoylcarnitine, and palmitoylcarnitine
standards. HPLC and MS conditions are described in the “Materials and
methods”
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As already published previously [16, 17], we prefer to
analyze carnitine and acylcarnitines without prior derivatiza-
tion. Frequently used derivatization procedures include the
formation of the methyl [13] or the butyl ester [18] as well
as the formation of the pentafluorophenacyl ester [15]. These
procedures use more time for sample preparation than a sim-
ple precipitation step, can therefore be less well automated and
butylation has the disadvantage that acylcarnitines may be
hydrolyzed during esterification [19]. Conversely, they have
the advantage to be more specific for the separation of
acylcarnitines with the same molecular mass [15].
Recovery and stability of the analytes
After having demonstrated a good separation for carnitine and
the most important acylcarnitines between C2 and C18, we
concentrated on the analysis of carnitine, acetylcarnitine,
octanoylcarnitine and palmitoylcarnitine. As shown inTable 1,
the recoveries of these four analytes were between 98 and
106 %. This is similar to the methods of Goshal et al. [25] and
Minkler et al. [15], who reported recoveries in the range of 84
and 112 and 83 to 107 %, respectively, for these compounds.
After addition of these four analytes to pooled plasma, they
were still stable after three freeze–thaw cycles. After 1 week
at −20 °C, acetylcarnitine and octanoylcarnitine showed a
drop by 7.4 and 11.4 %, respectively. Similarly, after 8 h at
room temperature, acetylcarnitine and octanoylcarnitine had
decreased by 5.9 and 6.4 %, respectively, whereas carnitine
and palmitoylcarnitine remained stable (Table 1).
Quantification and method validation
A second aim was to develop a methodminimizing the impact
of matrix effects on quantification of carnitine and
acylcarnitines. We first tested the feasibility of a classical
quantification with standard curves prepared in carnitine-free
matrices such as water or 4 % bovine serum albumin (BSA).
As shown in ESM Fig. S3A–D, the slopes of the standard
curves in water containing BSAwere different from the slopes
in pooled plasma for carnitine and acetylcarnitine, indicating a
significant matrix effect. Matrix effects have also been de-
scribed in the publication of Ho et al. [21] who analyzed free
and total carnitine after protein precipitation with acetonitrile,
and in the publication of Vernez et al. [17] who analyzed
carnitine and acylcarnitines after protein precipitation and
solid-phase extraction. An alternative could be the use of
denatured matrices such as dialyzed plasma [17, 27]. Dialysis
of plasma is time consuming, however, and the absence of
matrix effects should be demonstrated for every batch. We
therefore decided to validate and compare two different
methods of quantification, namely the SAM and the use of
external deuterated standards (DSM), which both account for
the observed matrix effect.
Accuracy of the two methods was assessed using three
QCs measured on three different days. The QCs were gener-
ated from pooled plasma, which was spiked with three known
concentrations (low, medium, and high concentration) of the
four analytes investigated (Table 2). The target values were
calculated by adding the spiked to the respective endogenous
concentration of the individual analytes in the pooled plasma.
For the SAM, the measured concentrations were within
±7.5 % of the expected concentrations for total carnitine and
carnitine in the entire concentration range tested. For
acetylcarnitine, octanoylcarnitine, and palmitoylcarnitine, the
variability was higher though not exceeding 15.4 % deviation
from the target values. For the DSM, the accuracy was in the
same range as for the SAM. The concentrations measured
were within 13 % of the expected values for the medium
and high concentrations and within 16 % for the low concen-
trations for all analytes.
The precision of the methods was determined using the three
QCs at different concentrations (low, medium, and high) as
described for the determination of the accuracy (Table 2) as well
as using plasma samples of six healthy volunteers (results not
shown). These samples were analyzed with both quantification
methods on three different days. For the SAM, themean interday
variation was below 10 % for free carnitine, acetylcarnitine,
octanoylcarnitine, palmitoylcarnitine, and total carnitine. None
of the individual coefficients of variation exceeded 17.7 %. For
the DSM, the interday precision was within 7.5% for all analytes
in the entire concentration range tested.
As shown for carnitine and octanoylcarnitine in ESM
Fig. S4, both methods were linear within the analyzed range
with coefficients of correlation of >0.99. Between the results
Table 1 Recovery and stability of the analytes
Carnitine species Recovery (%) Freeze–thaw stability (%) 1 week stability (%) 8 h stability (%) Stability of stock solution (%)
Carnitine 100.6±0.7 103.2±1.5 95.2±4.1 103.1±5.5 99.0±16.3
Acetylcarnitine 98.4±2.7 105.3±2.7 92.6±3.7 94.1±2.3 102.8±16.5
Octanoylcarnitine 102.3±3.8 103.7±3.7 89.6±7.1 93.6±2.9 110.0±24.9
Palmitoylcarnitine 105.6±2.2 103.6±4.1 95.8±1.2 98.7±6.3 99.2±27.8
Stability studies of the four analytes were performed on seven replicates of the three quality controls. Values are given as mean±coefficient of variation
(standard deviation expressed as a percentage of the mean)
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generated with the SAM and the DSM, we found correlations
ranging from 0.720 to 0.981. For carnitine we observed a
trend to higher values with the DSM, whereas for the other
analytes, the results were comparable (Fig. 2).
Regarding the sensitivity of our method, we defined the
lower limits of quantification (LLOQ) as the lowest concen-
tration of the respective deuterated standard measured with
reliable precision and accuracy. For octanoylcarnitine, the
LLOQ was 25 nmol/L and for palmitoylcarnitine 50 nmol/L.
LLOQ for carnitine and acetylcarnitine was 250 nmol/L.
These values are in the same range as reported by Ho et al.
[21] and by Hirche et al. [24].
The total carnitine concentration of a sample (the carnitine
concentration after hydrolysis of all acylcarnitines) provides
valuable information about the size of the carnitine pool and
the quality of the analysis of the individual carnitine species
(the sum of the individual carnitine species should equal the
total carnitine concentration). We therefore perform the deter-
mination of the total carnitine concentration routinely in all
samples that we analyze. Regarding the importance of this
determination, we assessed the total carnitine concentration
using both the SAM as well as the DSM and compared the
values with the radioenzymatic method. As shown in ESM
Table S1, there was a good agreement between the methods
used. The average of the largest difference between the values
obtainedwas 6.7% (range, 3.2 to 9.9%) of themean value. The
mean intercept of the correlations was 0.97 (range, −1.4 to 3.1),
the mean slope was 0.958 (range, 0.918 to 1.016), and the mean
r2 was 0.982 (range, 0.975 to 0.994).
Table 2 Accuracy and precision of the methods used for quantification
Carnitine species QCL QCM QCH
SAM DSM SAM DSM SAM DSM
Carnitine
Precision (CV %) 3.8 5.9 11.7 0.9 10.0 4.0
Accuracy (% expected) 106 108 103 112 101 108
Acetylcarnitine
Precision (CV %) 0.3 7.5 8.2 0.9 5.3 1.9
Accuracy (% expected) 95.2 99.8 90.4 110 84.6 110
Octanoylcarnitine
Precision (CV %) 12.8 3.9 17.7 2.9 14.3 1.1
Accuracy (% expected) 108 116 90.4 111 99.1 113
Palmitoylcarnitine
Precision (CV %) 9.5 0.9 10.4 5.4 10.9 5.9
Accuracy (% expected) 94.8 116 85.6 98.4 86.8 107
Total carnitine
Precision (CV %) 8.4 3.4 16.9 4.9 7.9 6.6
Accuracy (% expected) 98 103 92.5 92.8 98.4 100
Both accuracy and precision were assessed with three quality controls
(QC; low (QCL), medium (QCM), and high (QCH)) generated from
pooled plasma spiked with three different concentrations of carnitine
and three acylcarnitines. The expected concentration was calculated from
the concentration measured in pooled plasma plus the spiked concentra-
tions. The precision is expressed as coefficient of variation (CV; standard
deviation expressed as a percentage of the mean). The accuracy is given
as the ratio of the measured and the expected concentration expressed as a
percentage
SAM standard addition method, DSM deuterated standard method
Fig. 2 Carnitine (a) acetyl- (b),
octanoyl- (c), and
palmitoylcarnitine (d)
concentrations were measured
with the standard addition method
and with the deuterated standard
method. Both methods are
described in the “Materials and
methods.” The two methods were
compared using linear regression.
Concentrations are given in
micromoles per liter
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Comparison of the standard addition and the DSM
The SAM, which allows the quantification of the analytes in
the native matrix, completely eliminates the impact of matrix
effects on quantification. A disadvantage of this method is that
a single sample has to be analyzed five times to obtain a
reliable curve which can be used for quantification. Taking
into account the short analysis time, this disadvantage appears
to be acceptable. As the same standard solution in different
volumes is added to the plasma aliquots, a semi-automated
sample processing is possible. Together with the 30-min hy-
drolysis time for the determination of total carnitine, mixing
and centrifugation steps, the analysis of one sample for free
and total carnitine and acylcarnitines lasts approximately 1.5 h
and approximately 15 h for ten samples.
The DSM also minimizes the impact of matrix effects on
quantification and had a similar accuracy and precision com-
pared with the SAM.As two standard curves have to be run (one
for the hydrolyzed and one for the nonhydrolyzed samples), the
analysis of one sample takes approximately 2 h. For each new
sample, 20minmore are needed, resulting in 5 h for ten samples.
Ifmore than one sample has to be analyzed, theDSM is therefore
faster than the SAM. Disadvantages of the DSM are higher costs
for the deuterated standards and the possible lack of appropriate
standards for specific acylcarnitines.
Application of the method to biological samples
The SAM was applied for the quantification of carnitine
and three acylcarnitines in plasma samples of two patients
with medium-chain acyl-CoA dehydrogenase (MCAD)
deficiency and the DSM for the analysis of plasma samples
from a healthy volunteer completing a cycling exercise until
exhaustion.
As expected, the two patients with MCAD deficiency had
elevated plasmatic octanoylcarnitine concentrations [18, 26].
In the first patient, the octanoylcarnitine concentration was
more than ten times higher than in healthy volunteers and in
the second patient approximately 50 times higher. In the first
patient, also the palmitoylcarnitine concentration was elevated
while this was normal in the second patient. Carnitine and
acetylcarnitine concentrations were in a normal range in both
patients (Table 3).
In the healthy volunteer cycling until exhaustion, we
observed increasing acetylcarnitine concentrations with in-
creasing workload. In comparison, the free carnitine concen-
trations first slightly increased with exercise and then decreased
in parallel with increasing acetylcarnitine concentrations at
higher exercise intensities (Fig. 3). Increasing acetylcarnitine
concentrations in humans exercising above the lactate threshold
have been described earlier [3].
The two examples show that the method can be used
reliably for the quantification of carnitine and acylcarnitines
in patient samples. Further investigations have shown that the
method can easily be adapted for the analysis of other
acylcarnitines than those quantified in this study and is also
suitable for other matrices such as skeletal muscle and urine
(data not shown).
Table 3 Plasma concentrations of carnitine and acylcarnitines in two patients with MCAD deficiency
Patient 1 Patient 2 Reference values
SAM DSM SAM DSM SAM DSM
Carnitine 37.8 48.2 45.9 47.5 56.4±5.5 65.4±7.7
Acetylcarnitine 11.3 6.8 6.8 3.8 5.9±1.5 4.2±0.8
Octanoylcarnitine 1.1 1.0 4.2 4.7 0.08±0.03 0.05±0.02
Palmitoylcarnitine 0.59 0.51 0.10 0.13 0.10±0.02 0.08±0.03
The carnitine concentrations were measured with both the standard addition method (SAM) and deuterated standard method (DSM). Concentrations are
given in micromoles per liter. Reference values from healthy volunteers (n =10) are given as mean±SD
Fig. 3 The deuterated standard method was used for the quantification of
carnitine and acetylcarnitine in plasma samples of a healthy male volun-
teer completing a cycle exercise with increasing workload until exhaus-
tion. The workload started at 220 W and was increased by 20 W every
2 min. Exhaustion was reached after 18 min at 380 W. Mean concentra-
tions in micromoles per liter±SD of three determinations are shown
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Conclusions
In conclusion, we describe a fast and reliable method for the
analysis of carnitine and acylcarnitines requiring small sample
volumes and, in the case of the deuteratedmethod, a short total
analysis time. Our approach requiresminimal sample work-up
and can therefore be automated. The method is useful for
research projects with large numbers of specific analyses but
also for clinical applications.
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